Rankings
▼
Calendar
BOLD FY 2016 Earnings — Boundless Bio, Inc. Revenue & Financial Results | Market Cap Arena
BOLD
Boundless Bio, Inc.
$26M
FY 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$60M
Net Income
-$60M
EPS (Diluted)
$-5.59
Cash Flow
Operating Cash Flow
-$49M
Free Cash Flow
-$66M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$142M
Total Liabilities
$23M
Stockholders' Equity
$119M
Cash & Equivalents
$36M
← Q3 2016
All Quarters